Tempus AI, Inc. Director David R. Epstein Sells Shares

On March 17th, Director David R. Epstein of Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) sold 990 shares of the company’s stock. The shares were sold at an average price of $46.83, resulting in a total transaction value of $46,361.70. After this sale, Epstein now holds 26,284 shares in Tempus AI, which are valued at approximately $1,230,879.72. This sale reflects a decrease of 3.63% in his ownership of the stocks. Details of the transaction were filed with the SEC and can be accessed via the appropriate channels.

Tempus AI Stock Performance

On Wednesday, Tempus AI's shares increased by 5.0%, reaching a price of $48.03. The company experienced a trading volume of 11,624,616 shares compared to its usual volume of 5,018,028. Throughout the past year, Tempus AI has seen a low of $22.89 and a high of $91.45. Key financial ratios for the company include a quick ratio of 2.55, a current ratio of 2.69, and a debt-to-equity ratio of 8.17. Its fifty-day moving average stands at $55.86, while the 200-day moving average is recorded at $51.48.

Analyst Opinions

Recent analyst reports have provided varied insights on Tempus AI's stock. Loop Capital recently revised its target price for the stock down from $57.00 to $52.00, maintaining a "buy" rating. William Blair reiterated a "market perform" rating on February 25th. Piper Sandler lowered its price target from $70.00 to $55.00 and set a "neutral" rating on March 4th. Conversely, Needham & Company LLC raised its target from $56.00 to $70.00 and kept a "buy" rating. Additionally, Guggenheim affirmed a “buy” rating for the stock. Current consensus ratings show that six analysts support holding the stock, while another six recommend purchasing it, leading to an overall rating of "Moderate Buy" with an average target price of $61.18.

Institutional Ownership Trends

Several hedge funds have recently adjusted their stakes in Tempus AI. GSA Capital Partners LLP established a new position valued at $306,000 in the third quarter. First Horizon Advisors Inc. also bought shares valued at approximately $30,000 during the same period. The Manufacturers Life Insurance Company increased its holdings by 10.2%, owning a total of 29,789 shares valued at $1,686,000. Captrust Financial Advisors invested about $2,726,000, and NEA Management Company LLC significantly boosted its stake by 17.8%, owning 5,385,979 shares worth around $304,846,000. Overall, institutional investors and hedge funds control about 24.22% of the stock.

Overview of Tempus AI

Tempus AI Inc is a forward-thinking technology firm focusing on enhancing precision medicine through the effective use of artificial intelligence, primarily in the healthcare sector. The company provides advanced AI solutions that aid physicians in delivering personalized patient care while also contributing to the discovery and development of optimal therapeutics.

TempusAI, Shares, Transaction